NMTC Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
NeuroOne Medical Technologies Corp (NMTC) is not a good buy for a beginner, long-term investor at this time. The company is experiencing significant financial deterioration, with revenue, net income, and EPS all showing sharp declines. Technical indicators suggest a bearish trend, and there are no positive trading signals or catalysts to support a buy decision. Additionally, there is no recent news or influential trading activity to indicate potential upside.
The stock is in a bearish trend with SMA_200 > SMA_20 > SMA_5. The MACD is negative and contracting, while RSI is neutral at 38.065. The stock is trading near its support level of 0.666, with resistance at 0.742. Overall, technical indicators do not suggest a favorable entry point.
NULL. There are no recent news updates, significant insider or hedge fund activity, or congress trading data to suggest a positive catalyst.
Revenue dropped by -53.90% YoY, net income fell by -180.54% YoY, EPS declined by -150.00% YoY, and gross margin decreased by -30.98%. Additionally, no positive trading signals or sentiment indicators are present.
In Q1 2026, the company reported a revenue drop to $2,892,635 (-53.90% YoY), a net income decline to -$1,437,890 (-180.54% YoY), and an EPS drop to -0.03 (-150.00% YoY). Gross margin also fell to 54.2 (-30.98% YoY). These metrics indicate severe financial challenges.
No data available for analyst ratings or price target changes.
